122 filings
8-K
NAOV
NanoVibronix Inc
15 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
NAOV
NanoVibronix Inc
9 Apr 24
NanoVibronix Issues Letter to Stockholders
4:05pm
8-K
NAOV
NanoVibronix Inc
28 Mar 24
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
9:09am
8-K
NAOV
NanoVibronix Inc
17 Jan 24
Other Events
4:30pm
8-K
NAOV
NanoVibronix Inc
11 Dec 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
c0pknphpi0a
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
adubtuyg
28 Nov 23
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
9:00am
8-K
7dkvgw vu58n99yi
21 Nov 23
Other Events
8:30am
8-K
sl5vdvb3h6
14 Nov 23
NanoVibronix Issues Letter to Shareholders
12:00am
8-K
ce642bx
7 Nov 23
Receives Stocking Order from U.K. Distribution Partner in Anticipation of Increasing Demand
8:30am
8-K
4cb9dxzz3i5
27 Sep 23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:00am
8-K
dm2svh fe
6 Sep 23
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
8:30am
8-K
31i7gu3syj1k3jel4o
1 Sep 23
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:30pm
8-K
ps5a20 kt
30 Aug 23
NanoVibronix Cites Positive Results from Independent Testing of UroShield
8:30am
8-K
b7z9e023onsqr 58
29 Aug 23
Regulation FD Disclosure
4:05pm
8-K
lgzk2
28 Aug 23
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:30am
8-K
5w3gq5mkj16p 7ox
23 Aug 23
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
4:45pm
8-K
7pqsa
20 Jul 23
Other Events
4:45pm
8-K
5r0uy65tteox
21 Jun 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
1kr5w4uxvu82oh8
14 Jun 23
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
8:30am